Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China.

Emerg Microbes Infect · 2026 · PMC12912230 · PMID 41615771

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Similarly, for PT (118.14, 95.90, 101.36; P = 0.055 and P = 0.332) and FHA (36.65, 35.45, 43.40; P = 0.784 and P = 0.059), the differences between groups did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.